Login

Financial Snapshot

Revenue
TTM
$79.96M
Gross Margin
TTM
61.71%
Net Income
TTM
-$47.53M
Current Assets
2025 Q1
Current Liabilities
2025 Q1
Current Ratio
2025 Q1
61.26%
Total Assets
2025 Q1
Total Liabilities
2025 Q1
Book Value
2025 Q1
-5.889M
Cash
2025 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$32.34M

Stock Price

Loading...
Market Cap: $64.44 Million

About Akoya Biosciences, Inc.

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 205 full-time employees. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. The company offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays.

Industry: Laboratory Analytical Instruments Peers: Absci Corp Inotiv Inc Bionano Genomics Inc SomaLogic, Inc. Codexis Inc Quantum-Si Inc MaxCyte Inc Quanterix Corp Seer, Inc. Thermo Fisher Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support